DAPRODUSTAT for Nephrogenic anaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 859 adverse event reports in the FDA FAERS database where DAPRODUSTAT was used for Nephrogenic anaemia.
Most Reported Side Effects for DAPRODUSTAT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Hospitalisation | 219 | 16.3% | 8 | 219 |
| Product use issue | 116 | 8.6% | 21 | 59 |
| Off label use | 105 | 7.8% | 25 | 54 |
| Death | 91 | 6.8% | 91 | 13 |
| Haemoglobin decreased | 65 | 4.8% | 11 | 40 |
| Cardiac failure | 61 | 4.5% | 27 | 32 |
| Dysphagia | 58 | 4.3% | 12 | 41 |
| Renal impairment | 56 | 4.2% | 7 | 26 |
| Haemoglobin increased | 53 | 3.9% | 8 | 32 |
| Marasmus | 52 | 3.9% | 47 | 11 |
| Nephrogenic anaemia | 40 | 3.0% | 3 | 12 |
| Cerebral infarction | 39 | 2.9% | 13 | 31 |
| Condition aggravated | 39 | 2.9% | 15 | 19 |
| Fall | 39 | 2.9% | 12 | 31 |
| Pneumonia | 33 | 2.5% | 12 | 22 |
Other Indications for DAPRODUSTAT
Other Drugs Used for Nephrogenic anaemia
DARBEPOETIN ALFA (5,332)
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331)
ARANESP (1,740)
ERYTHROPOIETIN (750)
PEGZEREPOETIN ALFA (325)
EPOETIN ALFA-EPBX (169)
VADADUSTAT (140)
MIRCERA (100)
ENARODUSTAT (66)
ROXADUSTAT (57)